🚨SURVIVOR-WATCH — Late Effects + Recurrence Signals to Recognize
Most fears in survivorship — recurrence, cardiotoxicity, bone fracture, lymphedema progression, cognitive decline — are addressable when caught early. The patterns below are the high-leverage signals that warrant a same-day or urgent call. Severe symptoms = 911. Family often notices mood changes and cognitive slips before the survivor names them.
🎯Three Phases · One Force Field
Every square belongs to one of three phases of mastery. Inside each square's detail panel, the four sections — Concepts · Skills · Actions · Plan — are the building blocks of these phases. (Note: ASCO also describes three survivorship phases — acute, extended, permanent — that map onto the years after diagnosis. Don't confuse the two; they reinforce each other.)
📘 Learn It Tier 1 · Aware
Identity earned: Self-Advocate. The "know" — what survivorship is (acute vs extended vs permanent), the long-term and late effects you should expect, your treatment summary (subtype, anthracycline cumulative dose, trastuzumab duration, RT field, surgery), surveillance schedule, and the ASCO Survivorship Care Plan.
🛠 Live It Tier 2 · Active
Identity earned: Care-Team Member. The "do" — endocrine therapy adherence (the make-or-break behavior in HR-positive disease), the modifiable lifestyle stack (weight, exercise, Mediterranean diet, alcohol, sleep), arm measurements + symptom journal, mental-health screening with PHQ-9 / GAD-7, mammogram cadence, DXA tracking, the cardiotoxicity watch.
📣 Share It Tier 3 · Certified
Identity earned: Ambassador. The "carry forward" — body image, intimacy, fertility / early-menopause conversations; the BRCA / hereditary risk family conversation; mentor a newly-finished-treatment survivor via Susan G. Komen / SHARE / BCRF; advocate for equitable access (AA / Latina / rural disparities are real and addressable).
🛡️Your Force Field — 16 Squares
Click any square to open its detail panel. Each square is a tile in your shield. Keep clicking, learning, and acting — your Force Field gets stronger every step.
What Survivorship Is
The IOM defines survivorship as the period from diagnosis through the rest of life. ASCO splits it into three phases: acute (active treatment), extended (the first few years after), permanent (long-term, often years to decades). This sheet is for the post-treatment chapters — when active therapy ends and the long arc of surveillance, late effects, and recurrence prevention begins.
Primer360 Human Anatomy
Breast, Lymphatics & Treatment Effects
The breast sits over the chest wall; lymphatic drainage runs to the axilla (armpit). Surgery (lumpectomy or mastectomy) and especially axillary lymph-node procedures change drainage and create lymphedema risk. Radiation can cause skin changes, fibrosis, and adjacent-tissue effects (lung, heart with left-sided RT). Anthracyclines (doxorubicin, epirubicin) and trastuzumab can affect the heart. Knowing the anatomy makes the late-effect map make sense.
AnatomyWho Lives This — The Survivor Population
~4 million U.S. breast cancer survivors today. Most diagnoses are early-stage (I/II) and most are HR-positive (~70%) → years on endocrine therapy. ~15–20% are HER2-positive → trastuzumab. ~10–15% are triple-negative → more common in younger and AA women. ~12% lifetime risk for U.S. women. Disparities are real: AA women have ~40% higher mortality despite slightly lower incidence.
PrimerThe Numbers — Survival & Recurrence
5-year overall survival ~91% (early-stage closer to 99%). HR-positive recurrence risk persists for 20+ years (late recurrence is real — endocrine therapy matters for 5–10 years). HER2-positive recurrence risk highest in first 5 years. Triple-negative recurrence risk highest in first 3–5 years. Modifiable risk factors (BMI <25, ≥150 min/week exercise, alcohol ≤1 drink/day, Mediterranean diet) collectively reduce recurrence ~20–30% per WCRF/AICR + observational evidence.
PrimerRecognize Late Effects + Recurrence Signals
Late effects to know: lymphedema (arm swelling, heaviness, tightness), cardiotoxicity (SOB, chest pain, exertional fatigue — anthracycline / trastuzumab / RT), bone loss (silent until fracture — DXA), cognitive ("chemo brain"), peripheral neuropathy (taxane-induced), early menopause (hot flashes, GU symptoms). Recurrence signals: new persistent bone pain (axial spine/hip), new neuro deficits / severe headache, persistent SOB, new breast changes. Same-day call; severe = ED.
Learn ItSurveillance Schedule
Annual mammogram (the contralateral or remaining breast tissue at minimum; per ASCO/ACS — no routine MRI unless high-risk). Clinical breast exam q3–6 months for first 3 years, then annually. NO routine PET / CT / tumor markers in asymptomatic patients (ASCO Choosing Wisely). Symptom-based imaging only. Pelvic exam annually (especially on tamoxifen — endometrial cancer risk). DXA baseline + every 1–2 years on AIs. Lipid panel if on AIs. Echo / MUGA if on or post trastuzumab; cardio-oncology if anthracycline-exposed.
Learn ItKnow My Numbers + Treatment Summary
The survivor's lifetime data set: stage at diagnosis, ER / PR / HER2 status, subtype (HR+ / HER2+ / TNBC), genomic score (Oncotype DX, MammaPrint if used), treatment received (anthracycline cumulative dose mg/m², trastuzumab duration, RT field + dose, surgery type, axillary procedure), endocrine therapy + start date + planned duration, BRCA / hereditary status (if tested), mammogram cadence, DXA + lipids + LFTs. Bring this to every visit.
Learn ItLifestyle Force Field
Real recurrence-reduction evidence: weight management (BMI <25; weight gain after diagnosis associated with worse outcomes — WHEL, WINS, Nurses' Health Study). Exercise ≥150 min/week moderate + 2× resistance (ACSM Roundtable; among the strongest survivorship evidence). Mediterranean / DASH-style diet (WCRF/AICR). Alcohol ≤1 drink/day, ideally none (clear dose-response with recurrence in some studies). Smoking cessation. Sleep 7–9 hr. Vitamin D adequacy.
Learn ItEndocrine Therapy & Adherence — The Make-or-Break
HR-positive survivors: tamoxifen (premenopausal) or aromatase inhibitor (anastrozole, letrozole, exemestane — postmenopausal) for 5–10 years. Adherence is dismal in real-world data (~30–50% discontinue early) — yet adherence directly affects recurrence and mortality. Manage side effects to stay on therapy: hot flashes (gabapentin, SNRI, CBT), joint pain (exercise, switch agents, duloxetine), bone loss (DXA + bisphosphonate / denosumab), GU symptoms (vaginal moisturizers, low-dose vaginal estrogen with onc input). CYP2D6 + tamoxifen drug interactions (avoid potent inhibitors — paroxetine, fluoxetine, bupropion).
Live ItCare Team Members
Medical oncology (anchor) · breast surgery (when needed) · radiation oncology (if RT given) · PCP (transition over time, blood pressure, lipids, comorbidities) · cardio-oncology (if anthracycline / trastuzumab / RT to chest) · lymphedema-trained PT · pelvic-floor / sexual-health specialist · gynecology / menopause specialist · behavioral health (depression / anxiety prevalence ~30–40%) · genetic counseling (if BRCA / hereditary indication) · Susan G. Komen / SHARE / BCRF peer support.
Live ItTelemedicine & Tech
Tape-measure or perometer for serial arm circumference (lymphedema tracking) · symptom journal app (joint pain, hot flashes — to bring to oncology visits) · MyChart for labs, mammogram results, refills · video visits for survivorship clinic, behavioral health, sexual-health · medication reminder apps for endocrine therapy (the simplest highest-leverage intervention for adherence) · PHQ-9 + GAD-7 on the phone monthly · BP cuff + scale at home (AI metabolic monitoring) · ASCO Survivorship Care Plan template online.
TechInsurance, Cost & Help
Endocrine therapy is generic and inexpensive (most ≤$10/month). Trastuzumab biosimilars now common; copay programs exist for branded biologics. Mammograms covered by ACA preventive care. Survivorship-clinic visits typically covered. Lymphedema garments often partially covered (Lymphedema Treatment Act passed — Medicare now covers compression garments since 2024). Susan G. Komen Financial Assistance, CancerCare Co-Pay Assistance, Patient Advocate Foundation. FMLA for treatment recovery; ADA for cognitive accommodations long-term; SSDI case-by-case.
Live ItEquity, Access & the Disparity Story
The disparities are specific. AA women: ~40% higher mortality despite slightly lower incidence; triple-negative more common; younger age at diagnosis; access to oncology / radiation / clinical trials lags; underrepresentation in genomic testing. Latina women: later-stage at diagnosis; language and access barriers; family-history under-collection. Rural women: distance to specialty care; survivorship clinic access lags. Younger survivors (<40): fertility, body image, parenting, career disruption — different arc. Honest framing: cause matters less here than access does.
Share ItTalk to Kids, Partner, Employer
Kids: plain-language honesty about being "in survivorship now" — not "all done." Older kids may face hereditary-risk questions (BRCA testing conversation). Partner: intimacy, body image, early-menopause / GU symptoms, fertility loss — these are real and worth naming. The partner's role in adherence + recognizing late effects matters. Employer: ADA covers cognitive accommodations ("chemo brain"), schedule flex for surveillance imaging, and lymphedema garments. Most survivors return to full work; some need ongoing flex. Disclosure beyond direct supervisor is personal.
Share ItMentor & Share Insights
Susan G. Komen, SHARE Cancer Support, BCRF, Living Beyond Breast Cancer, Young Survival Coalition (for <40), Sisters Network (AA-focused), Latinas Contra Cancer all run peer mentor programs. The newly-finished-treatment survivor who hears "I'm 7 years out, I'm on year 6 of an AI, here's what I wish I'd known about the joint pain and how to keep going" gets a different orientation than one who only hears "you're done, congratulations." Honest framing about the long arc > pep talk.
Share ItJoin the ROI Study (PHIT)
PHIT — Population Health Impact Tracking. Aggregate & anonymous. Help prove this program improves outcomes — better endocrine adherence, earlier lymphedema referral, better cardiotoxicity surveillance, more PHQ-9 / GAD-7 screening uptake, earlier behavioral-health linkage, more equitable access for AA / Latina / rural survivors — for the breast cancer survivor population.
Study🩺 Hand-off to my Survivorship Team
Print and bring to your next visit. This page tells your team what you have prepared for, what you want to focus on, and how you would like to participate as an active member of your own care team.
- I am a Prepared Patient in training for breast cancer survivorship. I have reviewed all 16 squares of this Force Field Fact Sheet.
- I have started building my Health Passport, my treatment summary (subtype, anthracycline dose, trastuzumab duration, RT field, surgery, endocrine therapy + planned duration), my arm-measurement / symptom journal, my PHQ-9 + GAD-7 trend, and my endocrine therapy adherence log to bring to every visit.
- I want to teach back what I have learned and have you correct anything I have misunderstood — especially around my recurrence-risk picture, my mammogram and DXA cadence, my cardiotoxicity watch (anthracycline / trastuzumab / RT field), endocrine therapy plan, lymphedema referral threshold, BRCA / hereditary status, and when to call vs ED.
What helps my visit
Two minutes for me to teach back. One question I prepared. My Survivorship Care Plan. My med list (especially endocrine therapy) and CYP2D6-aware medication note if on tamoxifen. Confirm latest mammogram, DXA, lipid panel, echo (if applicable), PHQ-9 / GAD-7, surveillance schedule on the chart.
What I am working on
Endocrine adherence · weight management toward BMI <25 · ≥150 min/week exercise · Mediterranean-style diet · alcohol moderation · arm measurements + lymphedema vigilance · DXA-driven bone health · cardio-oncology check-ins if anthracycline / trastuzumab / left-sided RT · monthly PHQ-9 / GAD-7 · BRCA family conversation if applicable.
How I want to participate
Shared decisions. Be honest about late effects and recurrence risk. Tell me your top 1–2 priorities so we agree. Use AHRQ SHARE Approach. Refer to lymphedema PT at first sign. Cardio-oncology if anthracycline / trastuzumab / left-sided RT. Behavioral health early, not as last resort. Genetic counseling if any hereditary signal.
🔬 Help Prove This Works — Join the FFH ROI & PHIT Study
The Prepared Patient program is being studied to see whether better preparation actually improves outcomes — better endocrine therapy adherence, earlier lymphedema referral, better cardiotoxicity surveillance uptake, more PHQ-9 / GAD-7 screening, earlier behavioral-health linkage, more equitable access for AA / Latina / rural survivors, complete BRCA / hereditary risk testing where indicated — for breast cancer survivors. Your participation is voluntary, your data is aggregated and anonymized, and you can withdraw at any time.
➕ Add-On Force Field Card · Device or Skill Mastery
If your survivorship plan adds a device, treatment, or new skill, bolt on a 5-step Add-On Card. Common bolt-ons for breast cancer survivors: endocrine therapy adherence routine, lymphedema arm-measurement + compression-garment skill, DXA-driven bone health protocol (calcium / vit D / bisphosphonate), cardio-oncology echo cadence, PHQ-9 / GAD-7 monthly self-check, sexual-health / pelvic-floor PT routine, BRCA / genetic counseling visit, Survivorship Care Plan request, surveillance mammogram annual cadence, cognitive-rehab strategies for "chemo brain."
Introduce
What it is, why it matters, what it does
Coach
Watch a demo + walk-through
Practice
Do it with a coach watching
Train
Use it daily with a check-in
Test
Demonstrate competence + earn badge
Ready to go deeper?
The Prepared Patient · Breast Cancer Survivor course turns this fact sheet into a guided journey: pre/post knowledge checks, ASCO three-phase survivorship framing, treatment-summary literacy, endocrine therapy adherence, the modifiable lifestyle stack, lymphedema + cardiotoxicity + bone-health watch, PHQ-9 / GAD-7 mental-health rhythm, the Survivorship Care Plan, the BRCA / hereditary conversation, and your printable Health Passport. Earn Aware → Active → Certified.